Pluristem Therapeutics (PSTI) Granted Cell Manufacturing Patents in Several Markets
Tweet Send to a Friend
Pluristem Therapeutics (NASDAQ: PSTI) announced it has been granted patents covering cell manufacturing, pharmaceutical compositions and disease treatment in China ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE